Literature DB >> 33911198

FLT3-ITDos and FLT3-ITDon'ts: navigating maintenance therapy in FLT3-ITD-positive acute myeloid leukemia following stem cell transplantation.

Brittany Knick Ragon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33911198     DOI： 10.1038/s41409-021-01269-y

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  7 in total

1.  Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.

Authors:  Richard F Schlenk; Daniela Weber; Walter Fiedler; Helmut R Salih; Gerald Wulf; Hans Salwender; Thomas Schroeder; Thomas Kindler; Michael Lübbert; Dominik Wolf; Jörg Westermann; Doris Kraemer; Katharina S Götze; Heinz-August Horst; Jürgen Krauter; Michael Girschikofsky; Mark Ringhoffer; Thomas Südhoff; Gerhard Held; Hans-Günter Derigs; Roland Schroers; Richard Greil; Martin Grießhammer; Elisabeth Lange; Alexander Burchardt; Uwe Martens; Bernd Hertenstein; Lore Marretta; Michael Heuser; Felicitas Thol; Verena I Gaidzik; Wolfgang Herr; Julia Krzykalla; Axel Benner; Konstanze Döhner; Arnold Ganser; Peter Paschka; Hartmut Döhner
Journal:  Blood       Date:  2018-12-18       Impact factor: 22.113

2.  Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

Authors:  M Nakao; S Yokota; T Iwai; H Kaneko; S Horiike; K Kashima; Y Sonoda; T Fujimoto; S Misawa
Journal:  Leukemia       Date:  1996-12       Impact factor: 11.528

3.  Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

Authors:  Richard M Stone; Sumithra J Mandrekar; Ben L Sanford; Kristina Laumann; Susan Geyer; Clara D Bloomfield; Christian Thiede; Thomas W Prior; Konstanze Döhner; Guido Marcucci; Francesco Lo-Coco; Rebecca B Klisovic; Andrew Wei; Jorge Sierra; Miguel A Sanz; Joseph M Brandwein; Theo de Witte; Dietger Niederwieser; Frederick R Appelbaum; Bruno C Medeiros; Martin S Tallman; Jürgen Krauter; Richard F Schlenk; Arnold Ganser; Hubert Serve; Gerhard Ehninger; Sergio Amadori; Richard A Larson; Hartmut Döhner
Journal:  N Engl J Med       Date:  2017-06-23       Impact factor: 91.245

4.  Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN).

Authors:  Andreas Burchert; Gesine Bug; Lea V Fritz; Jürgen Finke; Matthias Stelljes; Christoph Röllig; Ellen Wollmer; Ralph Wäsch; Martin Bornhäuser; Tobias Berg; Fabian Lang; Gerhard Ehninger; Hubert Serve; Robert Zeiser; Eva-Maria Wagner; Nicolaus Kröger; Christine Wolschke; Michael Schleuning; Katharina S Götze; Christoph Schmid; Martina Crysandt; Eva Eßeling; Dominik Wolf; Ying Wang; Alexandra Böhm; Christian Thiede; Torsten Haferlach; Christian Michel; Wolfgang Bethge; Thomas Wündisch; Christian Brandts; Susanne Harnisch; Michael Wittenberg; Heinz-Gert Hoeffkes; Susanne Rospleszcz; Alexander Burchardt; Andreas Neubauer; Markus Brugger; Konstantin Strauch; Carmen Schade-Brittinger; Stephan K Metzelder
Journal:  J Clin Oncol       Date:  2020-07-16       Impact factor: 44.544

5.  Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.

Authors:  Li Xuan; Yu Wang; Fen Huang; Zhiping Fan; Yajing Xu; Jing Sun; Na Xu; Lan Deng; Xudong Li; Xinquan Liang; Xiaodan Luo; Pengcheng Shi; Hui Liu; Zhixiang Wang; Ling Jiang; Chunzi Yu; Xuan Zhou; Ren Lin; Yan Chen; Sanfang Tu; Xiaojun Huang; Qifa Liu
Journal:  Lancet Oncol       Date:  2020-08-10       Impact factor: 41.316

Review 6.  Targeting FLT3 mutations in AML: review of current knowledge and evidence.

Authors:  Naval Daver; Richard F Schlenk; Nigel H Russell; Mark J Levis
Journal:  Leukemia       Date:  2019-01-16       Impact factor: 11.528

Review 7.  Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Ali Bazarbachi; Gesine Bug; Frederic Baron; Eolia Brissot; Fabio Ciceri; Iman Abou Dalle; Hartmut Döhner; Jordi Esteve; Yngvar Floisand; Sebastian Giebel; Maria Gilleece; Norbert-Claude Gorin; Elias Jabbour; Mahmoud Aljurf; Hagop Kantarjian; Mohamed Kharfan-Dabaja; Myriam Labopin; Francesco Lanza; Florent Malard; Zinaida Peric; Thomas Prebet; Farhad Ravandi; Annalisa Ruggeri; Jaime Sanz; Christoph Schmid; Roni Shouval; Alexandros Spyridonidis; Jurjen Versluis; Norbert Vey; Bipin N Savani; Arnon Nagler; Mohamad Mohty
Journal:  Haematologica       Date:  2020-04-02       Impact factor: 9.941
  7 in total
  1 in total

1.  Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification.

Authors:  Tong-Yoon Kim; Silvia Park; Daehun Kwag; Jong-Hyuk Lee; Joonyeop Lee; Gi-June Min; Sung-Soo Park; Young-Woo Jeon; Seung-Hawn Shin; Seung-Ah Yahng; Jae-Ho Yoon; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Jong-Wook Lee; Hee-Je Kim
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.